ArticleThe Journal of veterinary medical science2025
No evidence of bovine leukemia virus proviral DNA in a widely used commercially frozen semen in Japan.
Article in The Journal of veterinary medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Distribution and influence of single-nucleotide polymorphisms affecting bovine leukemia virus proviral load in semen and progeny derived from semen in Japanese Black cattle.The Journal of veterinary medical science · 2026Article
- Polymorphism ofPathogens (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bovine leukemia virus (BLV) is a global concern that significantly affects the productivity of dairy and beef cattle, leading to considerable economic losses. BLV is primarily transmitted through infected lymphocytes via both horizontal and vertical routes. Vertical transmission occurs through the colostrum, uterus, and placenta. Although the possibility of BLV transmission through infected semen during artificial insemination is a recognized concern. No such cases have been reported in Japan, while studies from other countries reported a low risk. In this study, we aimed to evaluate the presence of BLV provirus in commercially frozen semen to assess the potential risk of infection in Japan. A sufficient quantity of genomic DNA with adequate purity was extracted from 191 widely used commercially frozen semen samples obtained from top-ranking bulls in the annual market survey in Japan between 2000 and 2022 using the phenol-chloroform extraction method. No BLV provirus was detected in any of the 191 frozen semen samples using either BLV-CoCoMo-qPCR-2 targeting the BLV long-terminal repeat region or nested polymerase chain reaction targeting BLV gp51 env gene. Similarly, the results are consistent with reports from other countries. Therefore, the findings of this study suggest a low risk of BLV transmission through frozen semen in Japan. Our study further supports that artificial insemination combined with the selection of non-infected cows for breeding are effective measures to prevent the spread of infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.